Conn M. Harrington, BA

Clinical Investigation Lead
ViiV Healthcare
Research Triangle Park, NC

Disclosure: ViiV Healthcare: Employee

Presentation(s):

• 884 - Patient Adherence to Long-Acting Injectable Cabotegravir + Rilpivirine through 48 Weeks of Maintenance Therapy in the Phase 3 ATLAS and FLAIR Studies

  Thursday, October 3
  3:30 PM – 3:45 PM